Form 8-K - Current report:
SEC Accession No. 0001104659-17-044833
Filing Date
2017-07-13
Accepted
2017-07-13 16:37:03
Documents
9
Period of Report
2017-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-17166_28k.htm 8-K 40226
2 EX-1.1 a17-17166_2ex1d1.htm EX-1.1 262087
3 EX-5.1 a17-17166_2ex5d1.htm EX-5.1 18422
4 EX-99.1 a17-17166_2ex99d1.htm EX-99.1 10925
5 EX-99.2 a17-17166_2ex99d2.htm EX-99.2 11106
6 GRAPHIC g171662mm03i001.gif GRAPHIC 6316
7 GRAPHIC g171662mm01i001.gif GRAPHIC 6316
8 GRAPHIC g171662kii001.jpg GRAPHIC 3295
9 GRAPHIC g171662kii002.jpg GRAPHIC 2372
  Complete submission text file 0001104659-17-044833.txt   369652
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 17963889
SIC: 2834 Pharmaceutical Preparations